Transforming the latest developments in aging research into therapies targeting age-related diseases

With rapid advances in the understanding of the underlying biology and mechanisms of aging, ground-breaking research and technology are coming together to target aging pathways, in a way to prevent, reverse or delay the onset of age-related conditions, and consequently improve heathspan.

The 2nd Longevity Therapeutics 2020 Summit will once again bring together 80+ leading experts in aging-related research, including biotechs, pharma, academics and investors, who are committed to serving worldwide population with innovative drugs to prevent, delay and treat age-related conditions.

Join us in San Francisco and be part of this exciting community – we’ve come to the crossroad to accelerate longevity therapeutics preclinical study into clinic. It’s only through collaborative and open discussions can we tackle challenges and find solutions, particularly in regulatory framework and commercialization.

Make 2020 your year to influence longevity therapeutics drug development!

"The conference brought together the best minds in the nascent longevity biotechnology industry. A good mix of old-school gerontologists taking metformin to the next level and young promising start-ups!”

2019 Attendee



"A huge success for everyone who attended. The participants were top notch. I learned a lot and made some good contacts. The content was extremely strong overalll”

2019 Attendee



Confirmed Partners 2020

Confirmed Media Partners 2020

AAA Logo transparent